ClinConnect ClinConnect Logo
Search / Trial NCT06910930

Impact of Muscle Training Device on Non-Severe OSA

Launched by THAMMASAT UNIVERSITY HOSPITAL · Mar 28, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Device Emst Powerbreathe Didgeridoo Didgeri Tu Expiratory Muscle Exercise Reverse Cpap

ClinConnect Summary

This clinical trial is looking at a new device called DidgeriTU, which is designed to help people with mild to moderate obstructive sleep apnea (OSA). The main goal is to see if using this device can reduce the number of breathing interruptions, known as apnea events, during sleep. Participants in the study will either use DidgeriTU or a fake device (called a sham device) for three months. Throughout the study, they will fill out an online questionnaire once a month and complete some tests at the beginning and end, including a sleep test, lung function test, and tongue strength test.

To be eligible for the trial, participants need to be at least 18 years old and have been diagnosed with mild to moderate OSA. However, people with very mild or very severe cases of OSA, those who cannot stop using their current sleep apnea treatments, or anyone with certain health conditions that affect muscle function may not qualify. This study is currently recruiting participants, and it offers a chance to explore a potentially helpful treatment for those struggling with sleep apnea.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients diagnosed with mild to moderate obstructive sleep apnea.
  • Age 18 years or older.
  • Patients voluntarily consent to provide information for research purposes.
  • Exclusion Criteria:
  • Patients with an average apnea-hypopnea index (AHI) of \<4 or \>29 events per hour after repeated diagnosis using a home sleep apnea test.
  • Patients who refused to cease using CPAP during the study process
  • Patients with a history of chronic lung disease.
  • Elderly patients with neurological conditions that impair cognitive function, such as dementia, stroke, or psychiatric disorders.
  • Patients taking medications that may affect muscle function within 3 months before the start of the study.
  • Patients with hypothyroidism or other conditions that may affect muscle function.
  • Patients who consume alcohol at a moderate level or higher

About Thammasat University Hospital

Thammasat University Hospital is a leading academic medical institution in Thailand, dedicated to advancing healthcare through innovative research and clinical trials. Affiliated with Thammasat University, the hospital integrates education, research, and patient care, fostering an environment that promotes scientific inquiry and the development of new therapeutic interventions. With a commitment to excellence, Thammasat University Hospital collaborates with various stakeholders to conduct rigorous clinical trials that aim to improve patient outcomes and contribute to the global medical community. Its multidisciplinary team of healthcare professionals ensures the highest standards of ethics and safety in all research activities.

Locations

Pathum Thani, , Thailand

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported